Sentences with phrase «estrogen therapy for»

That is also why some physicians consider prescribing estrogen therapy for osteoporosis.

The sooner you have bone density checked, the sooner you can begin estrogen therapy for osteoporosis prevention.

Estrogen therapy for women comes in many different forms.

Not exact matches

Estrogen Therapy covers a mirade of reproductive health issues for women NOT JUST BIRTH CONTROL.

It turned out that absolute risks were smaller for 50 - to 59 - year - olds than they were for older women, especially those 70 to 79 years old, for both combined therapy and estrogen alone.

In 2004, researchers published results of the WHI study of estrogen - only therapy, taken for about seven years by women who had had their uteruses surgically removed.

By replacing the natural estrogen lost during menopause, hormone replacement therapy could be one way for women to regain the cardiovascular benefits of estrogen, Arnson said.

Hormone replacement therapy (HRT) is a system of medical treatment for perimenopausal and postmenopausal women, based on the assumption that it may prevent discomfort and health problems caused by diminished circulating estrogen hormones.

«Although oral estrogens are effective for managing menopause symptoms, not enough is known about the cardiovascular safety of different oral hormone therapy products relative to each other,» said first author Nicholas L. Smith, PhD.

Researchers at the Kaiser Permanente Center for Health Research in Portland, Ore., concluded there is definitely a link between breast cancer and the use of menopausal hormone therapy, particularly estrogen - progestin treatment combinations.

Since the report that it did cause breast cancer and many women have stopped taking hormone replacement therapy, we've seen a decrease in breast - cancer incidence, exactly what you'd predict for our understanding of how estrogens work.

Because it tests negatively for estrogen and progesterone receptors, it is unresponsive to hormonal therapies.

More discouraging news about hormone replacement therapy for menopausal women appeared in June: Women taking Prempro, the most widely prescribed pill containing both estrogen and progestin, are more likely to develop Alzheimer's and to have early breast tumors that go undetected by mammograms.

«This could be very applicable for women suffering from hot flashes or depression for whom estrogen therapy is really counter-indicated,» says neuropharmacologist Roberta Brinton of the University of Southern California in Los Angeles, who was not involved in the new work.

Triple - negative cancers are so called because they do not express receptors for the hormones estrogen and progesterone, nor for HER2 (human epidermal growth factor 2), and hence patients with these cancers are not candidates for treatment with modern hormonal therapies or the highly effective HER2 - targeted drug Herceptin (trastuzumab).

Hormonal therapy for patients with estrogen - or progesterone - positive breast cancers can reduce the risk of cancer recurrence by as much as 50 percent.

Hot flashes are particularly severe and frequent in breast cancer survivors, but current FDA - approved remedies for these unpleasant episodes, such as hormone replacement therapies are off - limits to breast cancer survivors because they include estrogen.

«Preclinical studies suggest a possible benefit of estrogen therapy when combined with exercise to increase strength and performance and to prevent the loss of muscle mass, but the role of estrogen in muscle mass is not yet clear for postmenopausal women,» says Dr. JoAnn Pinkerton, executive director of NAMS.

Currently, there are no molecularly targeted therapies aimed at triple - negative breast cancer, which is a type of cancer negative for estrogen receptor, progesterone receptor and the HER2 protein — all key targets for current therapies.

«This study provides a foundation for future studies to evaluate the value of psycho - social interventions, such as cognitive therapies, to lessen the effect of major life events, as well as the use of estrogen therapy during perimenopausal and menopausal stressful times.»

Half of the postmenopausal women had been on estradiol, a type of estrogen therapy, for approximately five years, while the others had received a placebo.

Highly dependent on their estrogen receptors for growth and survival, these tumor cells are sensitive to hormonal therapies, making drugs like tamoxifen and fulvestrant effective first - line therapies for many patients.

It was used in this study for the first time to study factors that cause estrogen receptor positive breast cancer to recur during tamoxifen therapy.

Potential cardioprotection was based on generally supportive data on lipid levels in intermediate outcome clinical trials, trials in nonhuman primates, and a large body of observational studies suggesting a 40 % to 50 % reduction in risk among users of either estrogen alone or, less frequently, combined estrogen and progestin.2 - 5 Hip fracture was designated as a secondary outcome, supported by observational data as well as clinical trials showing benefit for bone mineral density.6, 7 Invasive breast cancer was designated as a primary adverse outcome based on observational data.3, 8 Additional clinical outcomes chosen as secondary outcomes that may plausibly be affected by hormone therapy include other cardiovascular diseases; endometrial, colorectal, and other cancers; and other fractures.3, 6,9

These results, also presented at the 2015 European Cancer Congress (ECC2015, abstract # 5BA) today, which involve the group of 1,626 patients with a Recurrence Score between 0 and 10, demonstrated that 99.3 percent of node - negative, estrogen receptor (ER)- positive, human epidermal growth factor receptor 2 (HER2)- negative patients who met accepted guidelines for recommending chemotherapy in addition to hormonal therapy, had no distant recurrence at five years after treatment with hormonal therapy alone.

Cancers that are positive for estrogen receptors, progesterone receptors, and HER2 can be treated with hormone therapies and drugs that target HER2.

International Agency for Research on Cancer, Combined estrogen - progestogen contraceptives and combined estrogen - progestogen menopausal therapy.

Is this the right decision, and do you even need a prescription for estrogen therapy?

For a comprehensive look at the benefits of estrogen therapy, check out this article.

Whether that treatment protocol turns out to be estrogen replacement therapy or testosterone replacement therapy, for women, the right hormone replacement therapy can be a game changer — click the button to find out more.

Research has shown that bioidentical estrogen is important for both safety and improved effectiveness, which is why we only use bioidentical hormones in estrogen replacement therapy.

The treatment for weight gain associated with low estrogen or low testosterone is hormone replacement therapy.

If you're struggling with the symptoms of low estrogen, you may be a candidate for estrogen replacement therapy.

So, when we recommend estrogen or other hormonal replacement therapy as treatment for perimenopause, we are looking to restore a balance that will help you feel much healthier and more like yourself.

Estrogen replacement therapy has long been understood as a remedy for women who are suffering from a variety of side effects following menopause, but what many women don't know is that testosterone replacement therapy may also need to be added to the mix to properly balance hormone levels.

When we recommend hormone replacement therapy, we're looking to improve your overall hormonal balance — treatment for perimenopause isn't just about estrogen levels.

If deemed the right choice, you will then receive an estrogen therapy prescription for the type of estrogen best suited to your needs.

For many, the first choice is to get an estrogen therapy prescription from their doctors.

For years, the prevailing wisdom was that DUB could be cured through estrogen therapy.

For some men who have low testosterone levels that are not yet in a dire state, progesterone therapy with an aromatase blocker may help increase T while preventing the estrogen conversion that can lead to estrogen dominance and weight gain.

If you think low estrogen might be contributing to unwanted weight gain, you may be a candidate for estrogen replacement therapy.

While taking synthetic forms of progesterone and estrogen was a popular method of addressing menopause symptoms for a while, many women - and doctors - now feel hormone replacement therapy is simply not worth the risk.

However, if you're still experiencing problems with weight gain, we recommend reading more about ERT (estrogen replacement therapy), a treatment for hormonal imbalances we often recommend.

For the same reasons of safety and efficacy, we only use bioidentical hormones for estrogen replacement theraFor the same reasons of safety and efficacy, we only use bioidentical hormones for estrogen replacement therafor estrogen replacement therapy.

It may be that estrogen replacement therapy will be the best way for you to experience relief from the symptoms of perimenopause.

Although there are a variety of options for raising your estrogen levels and getting you back to feeling normal, at TCT, we focus on estrogen replacement therapy using a topical medication — a gel or cream.

Although bio-identical hormone therapy seems to work for most post-menopausal women for arthritis relief, there are a few women that still have arthritis and arthralgias in spite of the estrogen cream.

Vaginal estrogen therapy may also be used in women who have breast, cervical or ovarian cancer, and medical consultation must be sought for proper advice on its risks and benefits.

For these reasons, evaluation of hormone replacement therapy in men should assess not only testosterone, but both free and conjugated estrogens.

Hormone Replacement Therapy in the Geriatric Patient: Current State of the Evidence and Questions for the Future — Estrogen, Progesterone, Testosterone, and Thyroid Hormone Augmentation in Geriatric Clinical Practice: Part 2 *